Largazole pharmacokinetics in rats by LC-MS/MS. - Wikidata - awgldk - TriplyDB

Largazole pharmacokinetics in rats by LC-MS/MS.

Largazole pharmacokinetics in rats by LC-MS/MS.

http://www.wikidata.org/entity/Q37667033

about

Modulation of Activity Profiles for Largazole-Based HDAC Inhibitors through Alteration of Prodrug Properties Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation.

P2860

Q34063722-15187D7D-747F-4C33-BF69-71248B4124B1 Q40091545-9447A7C2-C894-42E7-B96E-F57FB344B3ED

P2860

Largazole pharmacokinetics in rats by LC-MS/MS.

http://www.wikidata.org/entity/Q37667033

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Largazole pharmacokinetics in rats by LC-MS/MS.

@en

Largazole pharmacokinetics in rats by LC-MS/MS.

@nl

type

label

Largazole pharmacokinetics in rats by LC-MS/MS.

@en

Largazole pharmacokinetics in rats by LC-MS/MS.

@nl

prefLabel

Largazole pharmacokinetics in rats by LC-MS/MS.

@en

Largazole pharmacokinetics in rats by LC-MS/MS.

@nl

P1433

Q37667033-566C4BFB-FB18-4AD8-B235-A0CEE768AD6C

P1476

Q37667033-9259C862-3864-4FAB-8145-9CF03FDC900A

P2093

Q37667033-7CAAAA09-2880-406D-91D4-9FAE449C4500

Q37667033-8FCAFEBC-909E-4098-A1C2-479E24936C84

Q37667033-B813CAD9-9155-4690-9000-EFE38FE87722

Q37667033-CFFAC8F1-D91A-4348-AA0A-A072CFC1CF7A

Q37667033-DB371A04-7567-4428-B345-DF45B0B1BE66

Q37667033-E18714A7-5912-4DF9-9814-5EE5139CBA63

Q37667033-F08CA9B0-1F93-4EDD-B62C-3E1880009186

Q37667033-F5623DEC-AA93-429C-980C-3ED712E1D803

P2860

Q37667033-058BC2C0-C06E-4E76-AC7E-65C7009A810C

Q37667033-148A3C68-2A3F-4304-BB28-BB3AA241A7B3

Q37667033-23EEFC4E-8D2E-4BDB-ADF7-468E9020CF6E

Q37667033-3589D51E-0A4E-46E9-A441-A86D927DC565

Q37667033-359DDEC7-09DB-4646-9444-CDF599A50CE0

Q37667033-3607371C-F866-4186-A44A-97D559B14A10

Q37667033-475AE907-C9DC-4655-B60F-6832A088BD12

Q37667033-47CF9C47-FCAF-41DC-9E07-15C9D40EC7D9

Q37667033-4B4455B5-F35A-455C-8BEF-DC0E41767235

Q37667033-68AE5A2B-E5A0-4E15-9664-6818D9EBB656

P304

Q37667033-A0AE96B7-4CCD-45D3-B373-FA6F8B4970E0

P31

Q37667033-8E99BC8A-A65D-49A2-9C40-CE74AB07622C

P356

Q37667033-A688B783-9D7C-41E7-A130-6A3DA37B74CF

P433

Q37667033-62EB142F-386C-4C1E-90F5-FD9217D00D68

P478

Q37667033-93C25DE3-54E5-429B-AB90-719A05C3F104

P50

Q37667033-2528233B-1183-4424-B80E-653DA58EACFB

Q37667033-DB325C6E-523E-4685-874E-6DB6C1BF2014

P577

Q37667033-27543D87-1668-4875-A80B-C7795DE52702

P5875

Q37667033-978FD81F-7378-4020-B31C-DA83F5EE5409

P698

Q37667033-317C2992-841C-4027-9B71-8C66191751D3

P932

Q37667033-8E0C3F60-9C41-4770-8800-6AD269179B16

P356

P1433

P1476

Largazole pharmacokinetics in rats by LC-MS/MS.

@en

P2093

Hartmut Derendorf

http://www.w3.org/2001/XMLSchema#string

Hendrik Luesch

http://www.w3.org/2001/XMLSchema#string

Jiyong Hong

http://www.w3.org/2001/XMLSchema#string

Lilibeth A Salvador

http://www.w3.org/2001/XMLSchema#string

Mingming Yu

http://www.w3.org/2001/XMLSchema#string

Qi-Yin Chen

http://www.w3.org/2001/XMLSchema#string

Yanxia Liu

http://www.w3.org/2001/XMLSchema#string

Yufei Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Structural Basis of the Antiproliferative Activity of Largazole, a Depsipeptide Inhibitor of the Histone Deacetylases

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

Total synthesis and biological evaluation of largazole and derivatives with promising selectivity for cancers cells.

Enantioselective total synthesis of (+)-largazole, a potent inhibitor of histone deacetylase.

Anticolon cancer activity of largazole, a marine-derived tunable histone deacetylase inhibitor.

Expression profile of class I histone deacetylases in human cancer tissues.

Total synthesis and biological mode of action of largazole: a potent class I histone deacetylase inhibitor.

In Vitro and In Vivo Osteogenic Activity of Largazole.

Non-linear mixed effects modeling - from methodology and software development to driving implementation in drug development science.

Largazole: from discovery to broad-spectrum therapy.

P304

1623-1640

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/MD12031623

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261033597

http://www.w3.org/2001/XMLSchema#string

P698

24658499

http://www.w3.org/2001/XMLSchema#string

P932

3967229

http://www.w3.org/2001/XMLSchema#string